Failure to Administer Seizure Medications Leads to Resident Seizures
Summary
The facility failed to obtain and administer scheduled seizure medications for a resident, resulting in the resident experiencing two seizures. Upon admission, the resident did not receive their prescribed anti-seizure medications, including Vimpat, Keppra, and Trileptal, due to the facility's inability to secure these medications from the pharmacy. The resident, who had a history of seizures and was severely cognitively impaired, missed multiple doses of these critical medications, leading to two seizures on the same day. The facility's staff, including the Director of Nursing and a Licensed Practical Nurse, were unaware of the medication delivery status and failed to notify the resident's medical provider about the unavailability of the medications. The facility's pharmacy did not deliver the medications until after the resident had already missed several doses, and there was no evidence of the facility contacting the pharmacy for a STAT delivery or using a backup pharmacy. Additionally, the facility lacked emergency medications such as injectable Ativan or Valium, which could have been used to manage prolonged seizures. The facility's policies for handling unavailable medications were not followed, and there was a lack of communication between the facility, the pharmacy, and the resident's medical provider. The failure to administer the prescribed seizure medications and the absence of emergency medications in stock contributed to the resident's seizures, highlighting significant lapses in medication management and emergency preparedness.
Removal Plan
- The provider was notified of the resident's seizure history and order for PRN medication received.
- Review of residents with seizure disorder and last seizure date completed.
- Care Plans have been reviewed and reflect current seizure/epilepsy standards.
- Licensed Nursing staff educated on: A. What to do if a medication is not available. B. Pharmacy process for ordering medication and checking on order status using the pharmacy portal, phone, and messaging system. C. How to use the emergency stock medication. D. Updated Seizure policy. E. New admission clarification for need for PRN medication. F. Physician notification when medication not available. G. Delivery needs for any significant medication with any new admit.
- Review of emergency stock medication inventory by facility Physician/Medical Director.
- Facility to ensure review of admission to include review of potential residents with a history of seizure/other dx that could have a significant impact without medication prior to admission and if applicable, ask provider if any medications are not available, what substitutions can be made based on availability of medication in the emergency stock medication or if medication can be placed on hold.
- Facility to ensure continued compliance, Preadmission screen/admission question to provider if PRN antiseizure medication/medication that could have a significant impact without its administration is needed for new admission and then present to the QAPI for review. Audits will continue based on the recommendations of the QAPI on review of the admission audit findings.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.